-67%
Ascender Orthopedic And Bariatric Seating Solutions
Original price was: $303.00.$98.99Current price is: $98.99.
Seating is engineered to be comfortable and functional. The chairs enhance the patient’s ability to achieve a higher level of independence by maximizing sit to stand capability. Patient effort and risk associated with it is reduced with the “lifting” injury to the caregiver. The “hip” chair…
- Safe Payments, Happy Customers
- Shop with Confidence
- SSL encryption, absolutely safe shopping
- There are quality problems, free return and exchange
- Extended armrests and secure hand grips provide greater support when rising and sitting.
- Patented GLIDE-A-WAYâ„¢ footrest facilitates patient positioning when seated or during entry and exit.
- Hardwood frame provides stable seating platform and lab-tested weight bearing support.
- Patented seating technology maintains hip flexion below 90 degrees.
- New seat height standard of 25 inches is proven in scientific studies.
- Adjustable four-position back and three-position footrest ensure comfort and proper skeletal alignment.
- Seat and back cushions are interchangeable for modification of seat height and/or depth to meet the needs of a varied patient population.
WARNING: This product can expose you to chemicals including Cumene, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov
Be the first to review “Ascender Orthopedic And Bariatric Seating Solutions”
Related products
-72%
Original price was: $353.00.$99.99Current price is: $99.99.
-30%
Original price was: $30.64.$21.45Current price is: $21.45.
-30%
Original price was: $73.37.$51.36Current price is: $51.36.
-73%
Original price was: $367.00.$99.99Current price is: $99.99.
-37%
Original price was: $154.64.$97.99Current price is: $97.99.
-30%
Original price was: $95.44.$66.81Current price is: $66.81.
-30%
Original price was: $105.55.$73.89Current price is: $73.89.
-30%
Original price was: $124.18.$86.93Current price is: $86.93.
Reviews
There are no reviews yet.